review Open AccessTop 10% cited

Coronavirus Spike Proteins in Viral Entry and Pathogenesis

Virology · 2001 · Vol. 279(2) · pp. 371–374

Thomas Gallagher✉(Loyola University Medical Center)Michael J. Buchmeier(Scripps Research Institute)

SARS-CoV-2 and COVID-19 Research Animal Virus Infections Studies Viral gastroenteritis research and epidemiologyBiologyTissue tropismCoronavirusMouse hepatitis virusVirologyTropismCoronaviridaeVirusViral entryViral pathogenesis

MeSH terms

AnimalsBrainCell MembraneHumansMembrane GlycoproteinsMutationReceptors, VirusRNA, ViralViral Envelope ProteinsIn Situ HybridizationCoronavirusSpike Glycoprotein, Coronavirus

Funding

University of Pennsylvania

Citations

693

FWCI

11.25

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

Journal of Virology · 2003 · 1,568 citations

TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein

Journal of Virology · 2013 · 928 citations

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2

PLoS Pathogens · 2018 · 940 citations

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Journal of Clinical Medicine · 2020 · 568 citations

Coronavirus Spike Proteins in Viral Entry and Pathogenesis

Virology · 2001 · 693 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.